User profiles for J. Maris
John M MarisProfessor Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania Verified email at chop.edu Cited by 54504 |
Recent advances in neuroblastoma
JM Maris - New England Journal of Medicine, 2010 - Mass Medical Soc
Neuroblastoma, an embryonal cancer of the autonomic nervous system, is the most
common cancer diagnosed during the first year of life. Although neuroblastoma accounts for …
common cancer diagnosed during the first year of life. Although neuroblastoma accounts for …
Molecular biology of neuroblastoma
JM Maris, KK Matthay - Journal of clinical oncology, 1999 - ascopubs.org
PURPOSE AND RESULTS: Neuroblastoma, the most common solid extracranial neoplasm
in children, is remarkable for its clinical heterogeneity. Complex patterns of genetic …
in children, is remarkable for its clinical heterogeneity. Complex patterns of genetic …
[HTML][HTML] Malignant pheochromocytoma: current status and initiatives for future progress
Pheochromocytomas are rare catecholamine-producing neuroendocrine tumors that are
usually benign, but which may also present as or develop into a malignancy. Predicting such …
usually benign, but which may also present as or develop into a malignancy. Predicting such …
Identification of ALK as a major familial neuroblastoma predisposition gene
Neuroblastoma is a childhood cancer that can be inherited, but the genetic aetiology is largely
unknown. Here we show that germline mutations in the anaplastic lymphoma kinase (ALK…
unknown. Here we show that germline mutations in the anaplastic lymphoma kinase (ALK…
[HTML][HTML] Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
…, SD Gillies, SL Cohn, JM Maris… - … England Journal of …, 2010 - Mass Medical Soc
Background Preclinical and preliminary clinical data indicate that ch14.18, a monoclonal
antibody against the tumor-associated disialoganglioside GD2, has activity against …
antibody against the tumor-associated disialoganglioside GD2, has activity against …
The genetic landscape of high-risk neuroblastoma
Neuroblastoma is a malignancy of the developing sympathetic nervous system that often
presents with widespread metastatic disease, resulting in survival rates of less than 50%. To …
presents with widespread metastatic disease, resulting in survival rates of less than 50%. To …
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
Familial platelet disorder with predisposition to acute myelogenous leukaemia (FPD/AML,
MIM 601399) is an autosomal dominant disorder characterized by qualitative and quantitative …
MIM 601399) is an autosomal dominant disorder characterized by qualitative and quantitative …
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
The CD19 antigen, expressed on most B-cell acute lymphoblastic leukemias (B-ALL), can
be targeted with chimeric antigen receptor–armed T cells (CART-19), but relapses with …
be targeted with chimeric antigen receptor–armed T cells (CART-19), but relapses with …
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium …
Background Various human cancers have ALK gene translocations, amplifications, or
oncogenic mutations, such as anaplastic large-cell lymphoma, inflammatory myofibroblastic …
oncogenic mutations, such as anaplastic large-cell lymphoma, inflammatory myofibroblastic …
[PDF][PDF] Comprehensive analysis of hypermutation in human cancer
We present an extensive assessment of mutation burden through sequencing analysis of >81,000
tumors from pediatric and adult patients, including tumors with hypermutation caused …
tumors from pediatric and adult patients, including tumors with hypermutation caused …